Liver Fat Quantification by Magnetic Resonance Imaging (MRI) - Prediction of Postoperative Complications
NCT ID: NCT01234714
Last Updated: 2012-02-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
84 participants
OBSERVATIONAL
2010-10-31
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Magnetic Resonance Imaging (MRI) Fat Quantification of the Liver
NCT02682173
Hepatectomy Risk Assessment With Functional Magnetic Resonance Imaging
NCT04705194
Quantitative MRI and Outcomes of Liver Resection
NCT06181318
Fully Automated High-Throughput Quantitative MRI of the Liver
NCT05294471
Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI)
NCT01234701
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Major liver resection
This single Cohort/Group will include all consecutive patients that received pre-operative Magnetic Resonant Imaging (MRI) and underwent major liver resection (\>=3 segments).
Non-invasive Magnetic Resonance Imaging (MRI)
Conventional pre-operative MRI
Major liver resection
Hepatectomy of \>= 3 liver segments
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-invasive Magnetic Resonance Imaging (MRI)
Conventional pre-operative MRI
Major liver resection
Hepatectomy of \>= 3 liver segments
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients that received a pre-operative Magnetic Resonance Imaging (MRI).
* Patient over 18 years of age
Exclusion Criteria
* Patient that did not receive a pre-operative MRI
* Patient age less than 18 years of age.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dimitri A Raptis, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
University Hospital Zurich, Department of Visceral and Transplant Surgery, Zurich, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich, Department of Interventional and Diagnostic Radiology
Zurich, Canton of Zurich, Switzerland
University Hospital Zurich, Department of Visceral and Transplant Surgery, Swiss Hepato-Pancreato-Biliary (HPB) Center
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187-96. doi: 10.1097/SLA.0b013e3181b13ca2.
Raptis DA, Fischer MA, Graf R, Nanz D, Weber A, Moritz W, Tian Y, Oberkofler CE, Clavien PA. MRI: the new reference standard in quantifying hepatic steatosis? Gut. 2012 Jan;61(1):117-27. doi: 10.1136/gutjnl-2011-300155. Epub 2011 Oct 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MRI_Steatosis_Outcomes
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.